You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 19, May 17, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Health Agencies Update
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Variety=Destiny?

Joan Stephenson, PhD

JAMA. 2000;283:2514.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

For some people, acute infection with hepatitis C virus (HCV) leads to chronic illness; for a lucky minority—about 15% of those infected—a full recovery follows. Now, a new study published in the April 14 issue of Science indicates that events that take place soon after primary infection determine whether patients succeed in clearing virus from the body or whether they become chronically infected.

In the study, researchers at the National Institutes of Health, the University of Cagliari in Italy, and other institutions analyzed how viral genes coding for proteins that coat the surface of the virus evolved in patients who became infected with HCV from blood transfusions. Changes in surface proteins enable the virus to evade attack by the immune system.

The investigators found that in patients who successfully eliminated the virus, the surface protein genes remained relatively unaltered after the initial immune response. In contrast, the . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.